*Not available for sale in all countries. Please check with your local distributor for availability in your country.
Iridex provides office-based laser solutions for your retina practice. With the patented Fovea-friendly™ MicroPulse® laser technology there is a treatment option for the most common retinal diseases.
Iridex offers high quality laser systems, EndoProbe® handpieces, and a portfolio of vitreoretinal consumables for precision surgery in the hospital and ASC.
Iridex laser systems provide traditional, MicroPulse, and transscleral laser solutions for the management of glaucoma.
Iridex products offer the versatility of traditional, MicroPulse, and transscleral laser options for the treatment of both glaucoma and retinal diseases.
Iridex provides advanced laser solutions for ENT procedures. Our 532 nm laser systems, paired with specialized delivery devices, support precise treatment for select hearing loss procedures, as well as soft tissue and vascular lesions in the airway and larynx.
July 20, 2026: Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
April 07, 2026: Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology
Dec 11, 2025: Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management
Dec 8, 2025: Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment
July 29, 2025: Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema
March 19, 2025: Iridex Announces Strategic Investment in the Company